MannKind Corporation to host live broadcast of clinical trial for diabetes drug

For the first time, MannKind Corporation will host a live broadcast to review clinical results from its final two Phase 3 studies of AFRESA(TM). To participate in the live call by telephone, please dial (888) 677-5721 or (210) 839-8507. Those interested in viewing the live webcast via the Internet may do so by visiting the Company’s website at

Full article »

Protected by Comment Guard Pro